![]() |
**__Related stories:__***linkurl:Strangling the experimentalists: Opinion;http://www.the-scientist.com/news/display/57137/
[8th February 2010]*linkurl:"Study ethics, NIH!";http://www.the-scientist.com/blog/display/56151/
[17th November 2009]
Administrators at Sweden's premier medical university, the Karolinska Institute, announced today (March 2nd) that they've fired the institution's dean of research for exerting "undue influence" over the allocation of funds to top Karolinska professors.Image: Camilla Svensk Clinical pathologist linkurl:Karl Tryggvason;http://ki.se/ki/jsp/polopoly.jsp?d=17271&l=en reportedly tried to influence the decisions of an independent panel regarding which researchers at the Karolinska Institute should rec
![]() |
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this IssueLearn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.
Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.
New innovations provide scientists with easy access to robust and accurate control samples for quality control applications.
Setting new standards for intelligent mass detection, sensitivity, and sustainability.
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.
Discover how Alderley Analytical meet regulatory demands and high-throughput challenges—processing 10,000+ dirty samples with consistent performance of the Xevo TQ Absolute XR Mass Spectrometer.